Metraipolis › archive › dc_da9857377fe7
[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2-3, gastroenteropancreatic neuroendocrine tumours:… — Europe PMC PMID:42604001
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42604001
- DOI
- 10.1016/j.eclinm.2026.104109
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T23:22:37.270Z
- SHA-256 of the archived text
0359f3c8cd5dcff1a2a4648ac667f9027d598d3f93d1042480c5bcf862ee906b- Stable URL of this page
https://metraipolis.com/documento/dc_da9857377fe7
How to cite
[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2-3, gastroenteropancreatic neuroendocrine tumours:… — Europe PMC PMID:42604001 — Europe PMC (en), https://europepmc.org/article/MED/42604001 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da9857377fe7 (Metraipolis archive dc_da9857377fe7, sha256 0359f3c8cd5dcff1a2a4648ac667f9027d598d3f93d1042480c5bcf862ee906b)
BibTeX
@misc{dcda9857377fe7,
title = {[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2-3, gastroenteropancreatic neuroendocrine tumours:… — Europe PMC PMID:42604001},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42604001},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da9857377fe7; sha256 0359f3c8cd5dcff1a2a4648ac667f9027d598d3f93d1042480c5bcf862ee906b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42604001. Agents can read the archived copy with the MCP tool read_document.